Physician profile
John Yingling
NPI 1689749137
$479.83
in general payments reported to CMS, 2019-2025
8 companies · $14.95 in 2025
The $14.95 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $108 · 2023: $63.68 · 2024: $87.08 · 2025: $14.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $166.80 | 2021-2024 | Xtampza |
| Si-Bone, INC. | $100.68 | 2021-2022 | |
| Horizon Therapeutics Plc | $73.14 | 2021-2022 | |
| Depuy Synthes Sales INC. | $43.52 | 2024 | Orthovisc, Monovisc |
| Biodelivery Sciences International, INC. | $35.66 | 2021 | |
| Protega Pharmaceutials INC | $29.05 | 2024 | Roxybond |
| Pacira Therapeutics, INC. | $16.03 | 2021 | |
| Tonix Medicines, INC. | $14.95 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Yingling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.